Keywords
Last Name
Institution

RACHELLE S. S. DOODY

TitleDistinguished Emeritus Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
DivisionNeurology
Address7200 Cambridge Street, M.S. BCM609
9th Floor, Suite 9A
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Woodward MR, Amrutkar CV, Shah HC, Benedict RH, Rajakrishnan S, Doody RS, Yan L, Szigeti K. Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol Clin Pract. 2017 Feb; 7(1):5-14. PMID: 28243501.
      View in: PubMed
    2. Jia J, Wei C, Jia L, Tang Y, Liang J, Zhou A, Li F, Shi L, Doody RS. Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial. J Alzheimers Dis. 2017 Feb 01. PMID: 28157100.
      View in: PubMed
    3. Hammond FM, Alexander DN, Cutler AJ, D'Amico S, Doody RS, Sauve W, Zorowitz RD, Davis CS, Shin P, Ledon F, Yonan C, Formella AE, Siffert J. Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurol. 2016 Sep 02; 16(1):160. PMID: 27590297.
      View in: PubMed
    4. Liang FW, Chan W, Chen PJ, Zimmerman C, Waring S, Doody R. Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease. PLoS One. 2016; 11(8):e0160671. PMID: 27571265.
      View in: PubMed
    5. Hammond FM, Alexander DN, Cutler AJ, D'Amico S, Doody RS, Sauve W, Zorowitz RD, Davis CS, Shin P, Ledon F, Yonan C, Formella AE, Siffert J. PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurol. 2016; 16(1):89. PMID: 27276999; PMCID: PMC4899919.
    6. Bang J, Lobach IV, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Gold M, Morimoto BH, Boxer AL. Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials. Parkinsonism Relat Disord. 2016 Jul; 28:41-8. PMID: 27172829; PMCID: PMC4914418 [Available on 07/01/17].
    7. Benoit JS, Chan W, Luo S, Yeh HW, Doody R. A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified. Stat Med. 2016 Apr 30; 35(9):1549-57. PMID: 26782946; PMCID: PMC4821697 [Available on 04/30/17].
    8. Alverson WA, Massman PJ, Doody RS. Prevalence and correlates of cognitive asymmetry in a large sample of Alzheimer's disease patients. J Clin Exp Neuropsychol. 2016 Jun; 38(5):516-26. PMID: 26757777.
      View in: PubMed
    9. Balsis S, Benge JF, Lowe DA, Geraci L, Doody RS. How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond? Clin Neuropsychol. 2015; 29(7):1002-9. PMID: 26617181.
      View in: PubMed
    10. Doody RS, D'Amico S, Cutler AJ, Davis CS, Shin P, Ledon F, Yonan C, Siffert J. An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results. CNS Spectr. 2016 Dec; 21(6):450-459. PMID: 26471212.
      View in: PubMed
    11. Doody RS, Demirovic J, Ballantyne CM, Chan W, Barber R, Powell S, Pavlik V. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease. Alzheimers Dement (Amst). 2015 Dec; 1(4):464-71. PMID: 27239525; PMCID: PMC4879494.
    12. Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimers Res Ther. 2015; 7(1):39. PMID: 26120368.
      View in: PubMed
    13. Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimers Res Ther. 2015; 7(1):43. PMID: 26120369.
      View in: PubMed
    14. Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S, Frank L. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. Alzheimers Dement. 2016 Jan; 12(1):75-84. PMID: 26079412.
      View in: PubMed
    15. Doody RS, Raman R, Sperling RA, Seimers E, Sethuraman G, Mohs R, Farlow M, Iwatsubo T, Vellas B, Sun X, Ernstrom K, Thomas RG, Aisen PS. Peripheral and central effects of ?-secretase inhibition by semagacestat in Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):36. PMID: 26064192.
      View in: PubMed
    16. Vellas B, Bateman R, Blennow K, Frisoni G, Johnson K, Katz R, Langbaum J, Marson D, Sperling R, Wessels A, Salloway S, Doody R, Aisen P. Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2015 Jun; 2(2):128-135. PMID: 26247004.
      View in: PubMed
    17. Lowe DA, Balsis S, Benge JF, Doody RS. Adding delayed recall to the ADAS-cog improves measurement precision in mild Alzheimer's disease: Implications for predicting instrumental activities of daily living. Psychol Assess. 2015 Dec; 27(4):1234-40. PMID: 25938338.
      View in: PubMed
    18. Salmerón S, Huedo I, López-Utiel M, Soler-Moratalla I, Flores-Ruano T, Fernández-Sánchez M, Noguerón A, Doody RS, Abizanda P. Validation of the Spanish version of the Baylor Profound Mental Status Examination. J Alzheimers Dis. 2015; 49(1):73-8. PMID: 26444781.
      View in: PubMed
    19. Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler M, Jack CR, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol. 2014 Jul; 13(7):676-85. PMID: 24873720; PMCID: PMC4129545.
    20. Doody RS, Farlow M, Aisen PS. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. N Engl J Med. 2014 Apr 10; 370(15):1460. PMID: 24716687.
      View in: PubMed
    21. Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med. 2014 Jan 23; 370(4):311-21. PMID: 24450890.
      View in: PubMed
    22. Szigeti K, Kellermayer B, Lentini JM, Trummer B, Lal D, Doody RS, Yan L, Liu S, Ma C. Ordered subset analysis of copy number variation association with age at onset of Alzheimer's disease. J Alzheimers Dis. 2014; 41(4):1063-71. PMID: 24787912; PMCID: PMC4866488.
    23. Doody RS, Aisen PS, Iwatsubo T. Semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013 Oct 24; 369(17):1661. PMID: 24152267.
      View in: PubMed
    24. Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013 Jul 25; 369(4):341-50. PMID: 23883379.
      View in: PubMed
    25. Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen P. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013 Jul; 9(4):438-44. PMID: 23809364.
      View in: PubMed
    26. Spiegel R, Doody RS, Hendrix S, Kahle-Wrobleski K. Modeling the course of Alzheimer's disease to improve clinical trials: symposium report. Alzheimers Res Ther. 2013; 5(3):29. PMID: 23767782; PMCID: PMC3706927.
    27. Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R. Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response. BMC Geriatr. 2013; 13:56. PMID: 23742728; PMCID: PMC3681558.
    28. Ferris S, Cummings J, Christensen D, Doody R, Farlow M, Sabbagh M, Liu L, Mackell J, Fain R. Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity. Alzheimers Res Ther. 2013; 5(1):12. PMID: 23433097; PMCID: PMC4055003.
    29. Senanarong V, Harnphadungkit K, Poungvarin N, Vannasaeng S, Chongwisal S, Chakorn T, Jamjumrus P, Raksthaput A, Chaichanettee S, Aoonkaew N, Udompunthurak S, Doody RS, Cummings JL. The Dementia and Disability Project in Thai Elderly: rational, design, methodology and early results. BMC Neurol. 2013; 13:3. PMID: 23305293; PMCID: PMC3552988.
    30. O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, Edwards M, Grammas P, Wilhelmsen K, Doody R, Diaz-Arrastia R. Molecular neuropsychology: creation of test-specific blood biomarker algorithms. Dement Geriatr Cogn Disord. 2014; 37(1-2):45-57. PMID: 24107792; PMCID: PMC4400831.
    31. Szigeti K, Lal D, Li Y, Doody RS, Wilhelmsen K, Yan L, Liu S, Ma C. Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease. J Alzheimers Dis. 2013; 33(2):517-23. PMID: 23202439; PMCID: PMC4066557.
    32. Pavlik V, Massman P, Barber R, Doody R. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls. J Alzheimers Dis. 2013; 34(2):449-56. PMID: 23241558.
      View in: PubMed
    33. Havins WN, Massman PJ, Doody R. Factor structure of the Geriatric Depression Scale and relationships with cognition and function in Alzheimer's disease. Dement Geriatr Cogn Disord. 2012; 34(5-6):360-72. PMID: 23235472.
      View in: PubMed
    34. Li Y, Shaw CA, Sheffer I, Sule N, Powell SZ, Dawson B, Zaidi SN, Bucasas KL, Lupski JR, Wilhelmsen KC, Doody R, Szigeti K. Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer's disease. Transl Psychiatry. 2012; 2:e192. PMID: 23168992; PMCID: PMC3565761.
    35. Rountree SD, Atri A, Lopez OL, Doody RS. Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimers Dement. 2013 May; 9(3):338-45. PMID: 23102979.
      View in: PubMed
    36. Doody RS, Cummings JL, Farlow MR. Reviewing the role of donepezil in the treatment of Alzheimer's disease. Curr Alzheimer Res. 2012 Sep; 9(7):773-81. PMID: 22175653.
      View in: PubMed
    37. Zhang X, Li L, Zhang X, Xie W, Li L, Yang D, Heng X, Du Y, Doody RS, Le W. Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice. Neurobiol Aging. 2013 Mar; 34(3):663-78. PMID: 22795785.
      View in: PubMed
    38. Rountree SD, Chan W, Pavlik VN, Darby EJ, Doody RS. Factors that influence survival in a probable Alzheimer disease cohort. Alzheimers Res Ther. 2012; 4(3):16. PMID: 22594761; PMCID: PMC3506931.
    39. Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine. Dement Geriatr Cogn Disord. 2012; 33(2-3):164-73. PMID: 22572767.
      View in: PubMed
    40. Balsis S, Unger AA, Benge JF, Geraci L, Doody RS. Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores. Alzheimers Dement. 2012 Jul; 8(4):288-94. PMID: 22465173.
      View in: PubMed
    41. Luo S, Chan W, Detry MA, Massman PJ, Doody RS. Binomial regression with a misclassified covariate and outcome. Stat Methods Med Res. 2016 Feb; 25(1):101-17. PMID: 22421539; PMCID: PMC3883897.
    42. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 6; 109(10):3985-90. PMID: 22343285; PMCID: PMC3309762.
    43. Atri A, Rountree SD, Lopez OL, Doody RS. Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies. Neurodegener Dis. 2012; 10(1-4):170-4. PMID: 22327239; PMCID: PMC3702018.
    44. Miller TM, Balsis S, Lowe DA, Benge JF, Doody RS. Item response theory reveals variability of functional impairment within clinical dementia rating scale stages. Dement Geriatr Cogn Disord. 2011; 32(5):362-6. PMID: 22311305.
      View in: PubMed
    45. Lowe DA, Balsis S, Miller TM, Benge JF, Doody RS. Greater precision when measuring dementia severity: establishing item parameters for the Clinical Dementia Rating Scale. Dement Geriatr Cogn Disord. 2012; 34(2):128-34. PMID: 23006935; PMCID: PMC3557804.
    46. O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia R. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS One. 2011; 6(12):e28092. PMID: 22163278; PMCID: PMC3233542.
    47. Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, Obisesan TO, Rusinek H, Scharre D, Sperling R, Weiner MW, Green RC. The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage. 2012 Feb 15; 59(4):4196-200. PMID: 22100665; PMCID: PMC3676932.
    48. Pavlik VN, Doody RS. Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment. Alzheimers Res Ther. 2011; 3(5):30. PMID: 21999183; PMCID: PMC3218807.
    49. O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, Doody R, Fairchild T, Adams P, Wilhelmsen K, Diaz-Arrastia R. A blood-based algorithm for the detection of Alzheimer's disease. Dement Geriatr Cogn Disord. 2011; 32(1):55-62. PMID: 21865746; PMCID: PMC3169374.
    50. Szigeti K, Doody RS. Should persons with autosomal dominant AD be included in clinical trials? Authors' response. Alzheimers Res Ther. 2011; 3(3):19. PMID: 21631907; PMCID: PMC3226308.
    51. Balsis S, Miller TM, Benge JF, Doody RS. Dementia staging across three different methods. Dement Geriatr Cogn Disord. 2011; 31(5):328-33. PMID: 21555887.
      View in: PubMed
    52. Shaw CA, Li Y, Wiszniewska J, Chasse S, Zaidi SN, Jin W, Dawson B, Wilhelmsen K, Lupski JR, Belmont JW, Doody RS, Szigeti K. Olfactory copy number association with age at onset of Alzheimer disease. Neurology. 2011 Apr 12; 76(15):1302-9. PMID: 21482944; PMCID: PMC3090061.
    53. Doody RS, Cole PE, Miller DS, Siemers E, Black R, Feldman H, Schindler R, Graham S, Heath T, Khachaturian AS, Evans R, Carrillo MC. Global issues in drug development for Alzheimer's disease. Alzheimers Dement. 2011 Mar; 7(2):197-207. PMID: 21414556.
      View in: PubMed
    54. Szigeti K, Doody RS. Should EOAD patients be included in clinical trials? Alzheimers Res Ther. 2011; 3(1):4. PMID: 21345175; PMCID: PMC3109413.
    55. Kwon OD, Khaleeq A, Chan W, Pavlik VN, Doody RS. Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample. Dement Geriatr Cogn Disord. 2010; 30(6):486-91. PMID: 21252542.
      View in: PubMed
    56. Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li C, Goldman R. Identifying amnestic mild cognitive impairment in primary care: a feasibility study. Clin Drug Investig. 2011; 31(7):483-91. PMID: 21627337.
      View in: PubMed
    57. Zhang X, Heng X, Li T, Li L, Yang D, Zhang X, Du Y, Doody RS, Le W. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-? production in an aged Alzheimer's disease transgenic mouse model. J Alzheimers Dis. 2011; 24(4):739-49. PMID: 21321394.
      View in: PubMed
    58. Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, Pavlik V, Doody RS, Lyketsos CG. Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis. 2011; 27(2):259-69. PMID: 21841258; PMCID: PMC3218198.
    59. Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, Dubois B, Feldman HH, Petersen RC, Siemers E, Doody RS, Hendrix SB, Grundman M, Schneider LS, Schindler RJ, Salmon E, Potter WZ, Thomas RG, Salmon D, Donohue M, Bednar MM, Touchon J, Vellas B. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011 Jan 18; 76(3):280-6. PMID: 21178097; PMCID: PMC3034393.
    60. Doody RS. [Clinical trials in AD]. Rinsho Shinkeigaku. 2010 Nov; 50(11):835. PMID: 21921461.
      View in: PubMed
    61. O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, Waring S, Diaz-Arrastia R. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol. 2010 Sep; 67(9):1077-81. PMID: 20837851; PMCID: PMC3069805.
    62. Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Correction: Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010; 2(3):14. PMID: 20470369; PMCID: PMC2919694.
    63. Doody RS. Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design. J Nutr Health Aging. 2010 Apr; 14(4):299-302. PMID: 20306000.
      View in: PubMed
    64. Kunik ME, Snow AL, Davila JA, Steele AB, Balasubramanyam V, Doody RS, Schulz PE, Kalavar JS, Morgan RO. Causes of aggressive behavior in patients with dementia. J Clin Psychiatry. 2010 Sep; 71(9):1145-52. PMID: 20361896.
      View in: PubMed
    65. Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology. 2010 Mar 23; 74(12):956-64. PMID: 20200346.
      View in: PubMed
    66. Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010; 2(1):2. PMID: 20178566; PMCID: PMC2874261.
    67. Kunik ME, Snow AL, Davila JA, McNeese T, Steele AB, Balasubramanyam V, Doody R, Schulz PE, Kalavar JS, Walder A, Morgan RO. Consequences of aggressive behavior in patients with dementia. J Neuropsychiatry Clin Neurosci. 2010; 22(1):40-7. PMID: 20160208.
      View in: PubMed
    68. Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord. 2009; 28(6):536-40. PMID: 20016184; PMCID: PMC2866579.
    69. Doody RS, Ferris S, Salloway S. Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study. Am J Alzheimers Dis Other Demen. 2010 Mar; 25(2):155-9. PMID: 19949165.
      View in: PubMed
    70. Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology. 2009 Dec 15; 73(24):2061-70. PMID: 19923550; PMCID: PMC2790221.
    71. Crane PK, Doody RS. Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial. Neurology. 2009 Nov 3; 73(18):1514-5; author reply 1515-6. PMID: 19884584.
      View in: PubMed
    72. Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS. Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res Ther. 2009; 1(2):7. PMID: 19845950; PMCID: PMC2874259.
    73. Doody RS. Dimebon as a potential therapy for Alzheimer's disease. CNS Spectr. 2009 Aug; 14(8 Suppl 7):14-6; discussion 16-8. PMID: 19890242.
      View in: PubMed
    74. Benge JF, Balsis S, Geraci L, Massman PJ, Doody RS. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease? Dement Geriatr Cogn Disord. 2009; 28(1):63-9. PMID: 19641319.
      View in: PubMed
    75. Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Dis Assoc Disord. 2009 Jul-Sep; 23(3):260-7. PMID: 19812469; PMCID: PMC2762354.
    76. Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009 Mar; 5(2):85-92. PMID: 19328434; PMCID: PMC3959165.
    77. Snyder PJ, Papp KV, Bartkowiak J, Jackson CE, Doody RS. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors. Alzheimers Dement. 2009 Mar; 5(2):122-4. PMID: 19328439.
      View in: PubMed
    78. Doody RS. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease. Alzheimers Dement. 2009 Mar; 5(2):133-6. PMID: 19328443.
      View in: PubMed
    79. Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology. 2009 May 5; 72(18):1555-61. PMID: 19176895.
      View in: PubMed
    80. Na HR, Lee SH, Lee JS, Doody RS, Kim SY. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease. Dement Geriatr Cogn Disord. 2009; 27(1):69-75. PMID: 19145080.
      View in: PubMed
    81. Kelly PA, Dyer CB, Pavlik V, Doody R, Jogerst G. Exploring self-neglect in older adults: preliminary findings of the self-neglect severity scale and next steps. J Am Geriatr Soc. 2008 Nov; 56 Suppl 2:S253-60. PMID: 19016968; PMCID: PMC2743305.
    82. Doody RS. Cholinesterase inhibitors and memantine: best practices. CNS Spectr. 2008 Oct; 13(10 Suppl 16):34-5. PMID: 18955960.
      View in: PubMed
    83. O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol. 2008 Aug; 65(8):1091-5. PMID: 18695059; PMCID: PMC3409562.
    84. Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet. 2008 Jul 19; 372(9634):207-15. PMID: 18640457.
      View in: PubMed
    85. Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008 May; 4(3):156-63. PMID: 18631960; PMCID: PMC2544623.
    86. Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement. 2008 Mar; 4(2):145-53. PMID: 18631958.
      View in: PubMed
    87. Yan JH, Rountree S, Massman P, Doody RS, Li H. Alzheimer's disease and mild cognitive impairment deteriorate fine movement control. J Psychiatr Res. 2008 Oct; 42(14):1203-12. PMID: 18280503.
      View in: PubMed
    88. Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs Aging. 2008; 25(2):163-74. PMID: 18257603.
      View in: PubMed
    89. Doody RS. We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer's disease drug development. Alzheimers Dement. 2008 Jan; 4(1 Suppl 1):S21-5. PMID: 18631995.
      View in: PubMed
    90. Rountree SD, Waring SC, Chan WC, Lupo PJ, Darby EJ, Doody RS. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia. Dement Geriatr Cogn Disord. 2007; 24(6):476-82. PMID: 17992015.
      View in: PubMed
    91. Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology. 2007 Oct 16; 69(16):1622-34. PMID: 17938373.
      View in: PubMed
    92. Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord. 2007; 24(5):375-9. PMID: 17914262.
      View in: PubMed
    93. Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology. 2007 Jul 31; 69(5):459-69. PMID: 17664405.
      View in: PubMed
    94. Jack CR, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008 Sep; 29(9):1285-95. PMID: 17452062; PMCID: PMC2768818.
    95. Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM. Meta-analysis of six-month memantine trials in Alzheimer's disease. Alzheimers Dement. 2007 Jan; 3(1):7-17. PMID: 19595910.
      View in: PubMed
    96. Atchison TB, Massman PJ, Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type. Arch Clin Neuropsychol. 2007 Jan; 22(1):99-107. PMID: 17174522.
      View in: PubMed
    97. Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S124-38. PMID: 17135806.
      View in: PubMed
    98. Pavlik VN, Doody RS, Massman PJ, Chan W. Influence of premorbid IQ and education on progression of Alzheimer's disease. Dement Geriatr Cogn Disord. 2006; 22(4):367-77. PMID: 16954693.
      View in: PubMed
    99. Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, Banerjee S, Lin P, Sano M. Realistic expectations for treatment success in Alzheimer's disease. J Nutr Health Aging. 2006 Sep-Oct; 10(5):417-29. PMID: 17066215.
      View in: PubMed
    100. Dyer CB, Kelly PA, Pavlik VN, Lee J, Doody RS, Regev T, Pickens S, Burnett J, Smith SM. The making of a self-neglect severity scale. J Elder Abuse Negl. 2006; 18(4):13-23. PMID: 17972656.
      View in: PubMed
    101. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol. 2006 Jan; 63(1):49-54. PMID: 16401736.
      View in: PubMed
    102. Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmacother. 2006; 4 Suppl A:S9-S24; quiz S25-S28. PMID: 17157793.
      View in: PubMed
    103. Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W. Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord. 2005 Oct-Dec; 19(4):178-83. PMID: 16327343.
      View in: PubMed
    104. Román GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord. 2005; 20(6):338-44. PMID: 16192723.
      View in: PubMed
    105. Graham DP, Kunik ME, Doody R, Snow AL. Self-reported awareness of performance in dementia. Brain Res Cogn Brain Res. 2005 Sep; 25(1):144-52. PMID: 15919186.
      View in: PubMed
    106. Doody R, Pavlik V, Massman P, Kenan M, Yeh S, Powell S, Cooke N, Dyer C, Demirovic J, Waring S, Chan W. Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dement Geriatr Cogn Disord. 2005; 20(2-3):198-208. PMID: 16088145.
      View in: PubMed
    107. Snow AL, Graham DP, Molinari VA, Orengo CA, Doody RS, Norris MP, Kunik ME. Factors affecting deficit awareness in persons with dementia. Dement Geriatr Cogn Disord. 2005; 20(2-3):133-9. PMID: 16020941.
      View in: PubMed
    108. Doody RS. Refining treatment guidelines in Alzheimer's disease. Geriatrics. 2005 Jun; Suppl:14-20. PMID: 16025771.
      View in: PubMed
    109. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005 Jun 9; 352(23):2379-88. PMID: 15829527.
      View in: PubMed
    110. Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol. 2005 Mar; 62(3):454-9. PMID: 15767511.
      View in: PubMed
    111. Snow AL, Kunik ME, Molinari VA, Orengo CA, Doody R, Graham DP, Norris MP. Accuracy of self-reported depression in persons with dementia. J Am Geriatr Soc. 2005 Mar; 53(3):389-96. PMID: 15743279.
      View in: PubMed
    112. Graham DP, Cully JA, Snow AL, Massman P, Doody R. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord. 2004 Oct-Dec; 18(4):236-40. PMID: 15592137.
      View in: PubMed
    113. Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology. 2005; 24(1-2):42-50. PMID: 15459509.
      View in: PubMed
    114. Doody R, Wirth Y, Schmitt F, Möbius HJ. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord. 2004; 18(2):227-32. PMID: 15256834.
      View in: PubMed
    115. Snow AL, Norris MP, Doody R, Molinari VA, Orengo CA, Kunik ME. Dementia Deficits Scale. Rating self-awareness of deficits. Alzheimer Dis Assoc Disord. 2004 Jan-Mar; 18(1):22-31. PMID: 15198084.
      View in: PubMed
    116. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66. PMID: 14732621.
      View in: PubMed
    117. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol. 2003 Dec; 60(12):1696-702. PMID: 14676043.
      View in: PubMed
    118. Davis RN, Massman PJ, Doody RS. WAIS-R factor structure in Alzheimer's disease patients: a comparison of alternative models and an assessment of their generalizability. Psychol Aging. 2003 Dec; 18(4):836-43. PMID: 14692868.
      View in: PubMed
    119. Doody RS, Dunn JK, Huang E, Azher S, Kataki M. A method for estimating duration of illness in Alzheimer's disease. Dement Geriatr Cogn Disord. 2004; 17(1-2):1-4. PMID: 14560058.
      View in: PubMed
    120. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003 Aug 26; 61(4):479-86. PMID: 12939421.
      View in: PubMed
    121. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003 Apr 3; 348(14):1333-41. PMID: 12672860.
      View in: PubMed
    122. Doody RS. Current treatments for Alzheimer's disease: cholinesterase inhibitors. J Clin Psychiatry. 2003; 64 Suppl 9:11-7. PMID: 12934969.
      View in: PubMed
    123. Davis RN, Massman PJ, Doody RS. Effects of blood pressure on neuropsychological functioning in Alzheimer's disease. Arch Clin Neuropsychol. 2003 Jan; 18(1):19-32. PMID: 14591475.
      View in: PubMed
    124. Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, Knopman D, Kaye JA. A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial. Neurology. 2002 Feb 12; 58(3):433-7. PMID: 11839844.
      View in: PubMed
    125. Weiner MF, Doody RS, Sairam R, Foster B, Liao TY. Prevalence and incidence of major depressive disorder in Alzheimer's disease: findings from two databases. Dement Geriatr Cogn Disord. 2002; 13(1):8-12. PMID: 11731709.
      View in: PubMed
    126. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol. 2001 Dec; 58(12):1985-92. PMID: 11735772.
      View in: PubMed
    127. Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology. 2001 Aug 14; 57(3):481-8. PMID: 11502917.
      View in: PubMed
    128. Tangalos E, Doody R, Tariot P. Alzheimer's disease in long-term care: maximizing treatment options. J Am Med Dir Assoc. 2001 Jul-Aug; 2(4):H17-20. PMID: 12812557.
      View in: PubMed
    129. Doody RS, Dunn JK, Clark CM, Farlow M, Foster NL, Liao T, Gonzales N, Lai E, Massman P. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord. 2001 Jul-Aug; 12(4):295-300. PMID: 11351141.
      View in: PubMed
    130. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 May 8; 56(9):1154-66. PMID: 11342679.
      View in: PubMed
    131. Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol. 2001 Mar; 58(3):449-54. PMID: 11255449.
      View in: PubMed
    132. Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol. 2001 Mar; 58(3):427-33. PMID: 11255446.
      View in: PubMed
    133. Davis RN, Massman PJ, Doody RS. Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study. Alzheimer Dis Assoc Disord. 2001 Jan-Mar; 15(1):1-9. PMID: 11236819.
      View in: PubMed
    134. Doody RS. Mortality from pneumonia and hip fractures in patients with advanced dementia. JAMA. 2000 Nov 15; 284(19):2447; author reply 2448. PMID: 11074768.
      View in: PubMed
    135. Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2000 Nov; 69(5):668-71. PMID: 11032626; PMCID: PMC1763391.
    136. Rogers SL, Doody RS, Pratt RD, Ieni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol. 2000 May; 10(3):195-203. PMID: 10793322.
      View in: PubMed
    137. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000 Feb 23; 283(8):1007-15. PMID: 10697060.
      View in: PubMed
    138. Doody RS. The issue of representation in brain research. Brain Cogn. 2000 Feb; 42(1):26-8. PMID: 10739589.
      View in: PubMed
    139. Hanna PA, Doody RS. Alien limb sign. Adv Neurol. 2000; 82:135-45. PMID: 10624477.
      View in: PubMed
    140. Doody RS. Therapeutic standards in Alzheimer disease. Alzheimer Dis Assoc Disord. 1999 Nov; 13 Suppl 2:S20-6. PMID: 10622675.
      View in: PubMed
    141. Doody RS, Vacca JL, Massman PJ, Liao TY. The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease. Arch Neurol. 1999 Sep; 56(9):1133-7. PMID: 10488815.
      View in: PubMed
    142. Doody RS. Clinical benefits of a new piperidine-class AChE inhibitor. Eur Neuropsychopharmacol. 1999 Apr; 9 Suppl 2:S69-77. PMID: 10332937.
      View in: PubMed
    143. Doody RS, Strehlow SL, Massman PJ, Feher EP, Clark C, Roy JR. Baylor profound mental status examination: a brief staging measure for profoundly demented Alzheimer disease patients. Alzheimer Dis Assoc Disord. 1999 Jan; 13(1):53-9. PMID: 10192643.
      View in: PubMed
    144. Doody RS. Clinical profile of donepezil in the treatment of Alzheimer's disease. Gerontology. 1999; 45 Suppl 1:23-32. PMID: 9876215.
      View in: PubMed
    145. Doody R, Whitehouse PJ, Chen Q, Wang L, Wu Q, Rosser M, Xu XH. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1998 Dec; 12(4):263-5. PMID: 9876954.
      View in: PubMed
    146. Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998 May 11; 158(9):1021-31. PMID: 9588436.
      View in: PubMed
    147. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998 Jan; 50(1):136-45. PMID: 9443470.
      View in: PubMed
    148. Strite D, Massman PJ, Cooke N, Doody RS. Neuropsychological asymmetry in Alzheimer's disease: verbal versus visuoconstructional deficits across stages of dementia. J Int Neuropsychol Soc. 1997 Sep; 3(5):420-7. PMID: 9322400.
      View in: PubMed
    149. Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW. Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology. 1997 Jul; 49(1):44-50. PMID: 9222168.
      View in: PubMed
    150. Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, Morris JC, Fillenbaum GG, Heyman A. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease. Neurology. 1997 Jul; 49(1):70-5. PMID: 9222172.
      View in: PubMed
    151. Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:19-21. PMID: 9305509.
      View in: PubMed
    152. Antuono P, Doody R, Gilman S, Huff J, Scheltens P, Ueda K, Khachaturian ZS. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:22-5. PMID: 9305510.
      View in: PubMed
    153. Thal LJ, Carta A, Doody R, Leber P, Mohs R, Schneider L, Shimohama S, Silber C. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:46-9. PMID: 9305516.
      View in: PubMed
    154. Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S22-32. PMID: 9236949.
      View in: PubMed
    155. Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, Kumar R, Lucca U, Mangone CA, Mohr E, Morris JC, Rogers S, Sawada T. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:8-18. PMID: 9305508.
      View in: PubMed
    156. Sabbagh MN, Lynn P, Jhingran S, Massman P, Villanueva-Meyer J, Olup J, Doody RS. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1997; 9(1):68-74. PMID: 9017531.
      View in: PubMed
    157. Olin JT, Schneider LS, Doody RS, Clark CM, Ferris SH, Morris JC, Reisberg B, Schmitt FA. Clinical evaluation of global change in Alzheimer's disease: identifying consensus. J Geriatr Psychiatry Neurol. 1996 Oct; 9(4):176-80. PMID: 8970010.
      View in: PubMed
    158. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology. 1996 Mar; 46(3):720-6. PMID: 8618672.
      View in: PubMed
    159. Massman PJ, Doody RS. Hemispheric asymmetry in Alzheimer's disease is apparent in motor functioning. J Clin Exp Neuropsychol. 1996 Feb; 18(1):110-21. PMID: 8926290.
      View in: PubMed
    160. Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R. SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry. 1995 Oct; 152(10):1470-5. PMID: 7573586.
      View in: PubMed
    161. Kotrla KJ, Chacko RC, Harper RG, Doody R. Clinical variables associated with psychosis in Alzheimer's disease. Am J Psychiatry. 1995 Sep; 152(9):1377-9. PMID: 7653698.
      View in: PubMed
    162. Doody RS, Massman P, Mahurin R, Law S. Positive and negative neuropsychiatric features in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1995; 7(1):54-60. PMID: 7711492.
      View in: PubMed
    163. Doody RS. A reappraisal of localization theory with reference to aphasia. Part 1: Historical considerations. Brain Lang. 1993 Apr; 44(3):296-326. PMID: 8513406.
      View in: PubMed
    164. Doody RS. A reappraisal of localization theory with reference to aphasia. Part 2: Language theories from outside neurology. Brain Lang. 1993 Apr; 44(3):327-48. PMID: 8513407.
      View in: PubMed
    165. Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 1992 Sep; 55(9):806-10. PMID: 1402972; PMCID: PMC1015106.
    166. Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the Mini-Mental State. Examination of 'subtests'. Arch Neurol. 1992 Jan; 49(1):87-92. PMID: 1728269.
      View in: PubMed
    167. Feher EP, Doody RS, Whitehead J, Pirozzolo FJ. Progressive nonfluent aphasia with dementia: a case report. J Geriatr Psychiatry Neurol. 1991 Oct-Dec; 4(4):236-40. PMID: 1789913.
      View in: PubMed
    168. Doody RS, Rosenfield DB. Spasmodic dysphonia associated with palatal myoclonus. Ear Nose Throat J. 1990 Dec; 69(12):829-32. PMID: 2079007.
      View in: PubMed
    169. Feher EP, Doody R, Pirozzolo FJ, Appel SH. Mental status assessment of insight and judgment. Clin Geriatr Med. 1989 Aug; 5(3):477-98. PMID: 2680029.
      View in: PubMed
    170. Ornish D, Scherwitz LW, Doody RS, Kesten D, McLanahan SM, Brown SE, DePuey E, Sonnemaker R, Haynes C, Lester J, McAllister GK, Hall RJ, Burdine JA, Gotto AM. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983 Jan 7; 249(1):54-9. PMID: 6336794.
      View in: PubMed
    171. Doody RS, Grose NP. The family medical history: assessing patient understanding of diabetes mellitus. Diabetes Care. 1981 Mar-Apr; 4(2):285-8. PMID: 7215084.
      View in: PubMed
    DOODY's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _